To assist small and mid-size bio-pharma companies with necessary funds to complete their development milestones, MPR Inc. launches a new business unit to undertake Risk Sharing programs. The division financial deals evaluation and negotiation will be lead by the three of the Company Financial experts, Mr. Max Rashed, Mr. Marc Rich and Mr. George Kuzmanovski.

 

Scientific and market potential evaluation, including medical affairs, will be coordinated via scientific committees lead by Dr. Raj Kapoor and Dr. Feng Li.

 

This initiative also formally launches a campaign with professional and private fund managers in three international locations: USA, China and Gulf regions.